Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0370 | ||||
| Gene Name | SLC45A3 | ||||
| Protein Name | Solute carrier family 45 member 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | IPCA-2; IPCA-6; IPCA-8; IPCA6; PCANAP2; PCANAP6; PCANAP8; PRST; Prostate cancer-associated protein 6; Prostein; SLC45A3 | ||||
| DT Family | Glycoside-Pentoside-Hexuronide (GPH):Cation Symporter Family ; | ||||
| Tissue Specificity | Prostate specific. Expressed in all prostaticglandular cells. Expressed both in normal and cancerous prostates. | ||||
| Function | This membrane tranporter mediates the transport of sucrose and hexose. It can also regulation of fatty acid biosynthetic, glucose metabolic process, oligodendrocyte differentiation and sucrose transport. | ||||
| Endogenous Substrate(s) | Sucrose | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Sucrose
|
Phase 4 | Drug Info | Retinopathy of prematurity | 9B71.3 | [1] |
| References | |||||
| 1 | Putative role of the H(+)/sucrose symporter SLC45A3 as an osmolyte transporter in the kidney. Pflugers Arch. 2016 Aug;468(8):1353-62. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.